Quest Diagnostics’ study confirms accuracy of blood tests for Alzheimer’s disease diagnosis
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Subscribe To Our Newsletter & Stay Updated